CDKN2B-AS1, a protein involved in tumorigenesis, migration, invasion, and regulation of tumor cell apoptosis, is upregulated in HCC, is significantly associated with the growth of the disease, and can be used as a potential treatment or predictive biomarker for the various human diseases. This evidence concerns the gene CDKN2B and hepatocellular carcinoma.